Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 trial of the TD Vaccine System for prevention of travelers' diarrhea in travelers to Asia
2009-015603-10Phase 2Completed
- Sponsor
- Intercell AG
- Start
- Sep 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in traveler's diarrhea (TD) and Enterotoxigenic Escherichia coli diarrhea comparing TD Vaccine System with Placebo (2 arms). Primary endpoint: Primary efficacy endpoint. Started Sep 2009; status: completed.
02
Drugs
TD Vaccine System
03
Conditions
traveler's diarrhea (TD)Enterotoxigenic Escherichia coli diarrhea
Beyond the preview
Go deeper on 2009-015603-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015603-10.